News
Local
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate News
Hot Property
eNewspaper
________________
Subscriptions
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
About Us
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Events
Advertising
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Jobs
CaregiverSD
Community papers
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Games, Puzzles, and Crossword
Crossword
Sudoku
Crossword
Sudoku
Obituaries
Death Notices
Place an obituary
Death Notices
Place an obituary
U-T En Español
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Privacy and Terms
Privacy
Terms
Advertising terms
Privacy
Terms
Advertising terms
Copyright © 2022, The San Diego Union-Tribune |
CA Notice of Collection
|
Do Not Sell My Personal Information
Sections
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate
Obituaries
eNewspaper
Newsletters
Show Search
Search Query
Submit Search
COVID-19
For subscribers
Phenomenal women
Latino life
Crossword
Sudoku
About Us
Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Diego Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Ardelyx Inc
(NQ:
ARDX
)
6.650
+0.290 (+4.56%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Ardelyx Inc
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
3 Strong Buy Biotech Stocks to Add to Your February Must-Watch List
February 06, 2024
These biotech stocks offer investors huge potential in the future. Investors may want to consider these equities to enter the industry.
Via
InvestorPlace
The 3 Best Biotech Stocks to Invest in for Big Gains in 2024
February 02, 2024
These pivotal biotech stocks for gains are charting the future of medicine and investment growth in 2024 offering powerful returns
Via
InvestorPlace
Ardelyx to Report Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024
February 01, 2024
Conference call scheduled for 4:30 p.m. Eastern Time
From
Ardelyx, Inc.
Via
GlobeNewswire
3 Groundbreaking Biotech Stocks to Invest in Now
January 29, 2024
These are several biotech companies for investors seeking unique opportunities for great returns within the industry.
Via
InvestorPlace
Wedbush Maintains Outperform Rating for Ardelyx: Here's What You Need To Know
January 12, 2024
Via
Benzinga
Why Ardelyx Stock Is Climbing Higher
January 09, 2024
Via
Benzinga
What Analysts Are Saying About Ardelyx Stock
January 09, 2024
Via
Benzinga
What's Going On With Ardelyx Stock?
January 08, 2024
Ardelyx, Inc. (NASDAQ: ARDX) shares are trading higher Monday after the company provided a strategic business update.
Via
Benzinga
7 Small-Cap Stocks to Buy for Big Gains in 2024
January 29, 2024
Small-cap stocks are a great way to diversify your portfolio and set yourself up for some potentially dynamic gains.
Via
InvestorPlace
3 mid-caps under $20 that Wall Street loves
January 23, 2024
MarketBeat's Stock Screener tool helped identify these three mid-cap stocks - with very bullish Wall Street sentiment - that are currently under $20 per share
Via
MarketBeat
Topics
Artificial Intelligence
Economy
Exposures
Artificial Intelligence
Interest Rates
Ardelyx, Inc. Reports Employment Inducement Grants
January 12, 2024
From
Ardelyx, Inc.
Via
GlobeNewswire
The Latest Analyst Ratings for Ardelyx
December 01, 2023
Via
Benzinga
The 3 Best Under-$10 Stocks to Buy in January 2024
January 10, 2024
These are a few companies for investors looking for inexpensive options that still offer great earnings potential.
Via
InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
January 09, 2024
Via
Benzinga
Nvidia, Boeing, Ardelyx, Crocs, Tesla: Why These 5 Stocks Are On Investors' Radars Today
January 08, 2024
Via
Benzinga
Ardelyx Provides Update on Growing Commercial Momentum and 2024 Strategic Priorities
January 08, 2024
From
Ardelyx, Inc.
Via
GlobeNewswire
Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
January 08, 2024
Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates. Also, Needham maintained a Buy rating on...
Via
Benzinga
Ardelyx to Provide Company Update on IBSRELA® and Host a KOL Discussion on the IBS-C Landscape on Monday, January 8
January 03, 2024
Live event and webcast scheduled for 7:00 p.m. ET / 4:00 p.m. PT
From
Ardelyx, Inc.
Via
GlobeNewswire
Ardelyx, Inc. Reports Employment Inducement Grants
December 20, 2023
From
Ardelyx, Inc.
Via
GlobeNewswire
Positive News For Skin Health: Aldeyra Therapeutics' ADX-629 Achieves Key Milestones in Atopic Dermatitis Study
December 19, 2023
Aldeyra Therapeutics Inc (NASDAQ: ALDX) released topline results from a Phase 2 clinical trial of ADX-629, an investigational RASP modulator, in
Via
Benzinga
Patient Demand Drives Ardelyx's Constipation Drug Success Amid IBS-C Treatment Gap, Says Analyst
December 18, 2023
Raymond James initiated coverage of Ardelyx Inc (NASDAQ: ARDX), noting the company's two early-stage launches underway for the same molecule with differentiated pricing:
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
December 14, 2023
Via
Benzinga
3 Short-Squeeze Stocks Ready for a Year-End Rally
December 14, 2023
These are a few companies that have seen considerable gains this year that still have a large percentage of short interest.
Via
InvestorPlace
Ardelyx, Inc. Reports Employment Inducement Grants
November 21, 2023
From
Ardelyx, Inc.
Via
GlobeNewswire
7 Penny Stocks You’ll Regret Not Buying Soon: November 2023
November 21, 2023
Unlock robust upside potential by wagering on these top penny stocks to buy in a volatile market at this time.
Via
InvestorPlace
Ardelyx to Participate at the Piper Sandler 35th Annual Healthcare Conference
November 21, 2023
From
Ardelyx, Inc.
Via
GlobeNewswire
XPHOZAH® (tenapanor) Granted Orphan Drug Designation by U.S. FDA for the Treatment of Pediatric Hyperphosphatemia
November 15, 2023
From
Ardelyx, Inc.
Via
GlobeNewswire
Ardelyx Announces Departure of Board Member
November 13, 2023
From
Ardelyx, Inc.
Via
GlobeNewswire
Ardelyx to Participate at the Jefferies London Healthcare Conference
November 10, 2023
From
Ardelyx, Inc.
Via
GlobeNewswire
5 OTC Stocks With The Potential To Explode In 2024
November 08, 2023
Investors who are ready to dive into the OTC pool have more options than ever, both with the number of stocks to choose from and available investing platforms.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.